Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA)

Molecular Genetics and Metabolism

Volumn 91, Issue 2, 2007, Pages 148-156

  Bykhovskaya, Yelena ^a   Mengesha, Emebet ^a   Fischel Ghodsian, Nathan ^a  

^a Steven Spielberg Pediatric Research Center   (United States)

Author keywords

Expression; Microarray; Myopathy; Oxidative phosphorylation disorder; Pseudouridylation; Sideroblastic anemia

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TRANSCRIPTION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IRON METABOLISM; MALE; METAL BINDING; MICROARRAY ANALYSIS; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIDEROBLASTIC ANEMIA; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANEMIA, SIDEROBLASTIC; ANIMALS; CELL LINE; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; HYDRO-LYASES; IRON; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MITOCHONDRIAL MYOPATHIES; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PEDIGREE; PRINCIPAL COMPONENT ANALYSIS; PSEUDOURIDINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 34249008188     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.02.006     Document Type: Article

References (43)

1. Casas K.A., and Fischel-Ghodsian N. Mitochondrial myopathy and sideroblastic anemia. Am. J. Med. Genet. A125 (2004) 201-204
2. Bykhovskaya Y., Casas K.A., Mengesha E., Inbal A., and Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74 (2004) 1303-1308
3. Patton J.R., Bykhovskaya Y., Mengesha E., Bertolotto C., and Fischel-Ghodsian N. Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J. Biol. Chem. 280 (2005) 19823-19828
4. DiMauro S., and Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348 (2003) 2656-2668
5. DiMauro S. The many faces of mitochondrial diseases. Mitochondrion 4 (2004) 799-807
6. Antonicka H., Sasarman F., Kennaway N.G., and Shoubridge E.A. The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum. Mol. Genet. 15 (2006) 1835-1846
7. Behm-Ansmant I., Massenet S., Immel F., Patton J.R., Motorin Y., and Branlant C. A previously unidentified activity of yeast and mouse RNA:pseudouridine synthases 1 (Pus1p) on tRNAs. RNA 12 (2006) 1583-1593
8. Zhao X., Patton J.R., Davis S.L., Florence B., Ames S.J., and Spanjaard R.A. Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Mol. Cell 15 (2004) 549-558
9. Mochizuki Y., He J., Kulkarni S., Bessler M., and Masonl P.J. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc. Natl. Acad. Sci. USA 101 (2004) 10756-10761
10. Mitchell J.R., Wood E., and Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402 (1999) 551-555
11. Dokal I. Dyskeratosis congenita in all its forms. Br. J. Haematol. 110 (2000) 768-779
12. Morello F., de Bruin T.W., Rotter J.I., Pratt R.E., van der Kallen C.J., Hladik G.A., Dzau V.J., Liew C.C., and Chen Y.D. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia. Arterioscler Thromb. Vasc. Biol. 24 (2004) 2149-2154
13. Baron C.A., Liu S.Y., Hicks C., and Gregg J.P. Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J. Autism. Dev. Disord. 36 (2006) 973-982
14. Haas C.S., Creighton C.J., Pi X., Maine I., Koch A.E., Haines G.K., Ling S., Chinnaiyan A.M., and Holoshitz J. Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum 54 (2006) 2047-2060
15. Watts J.A., Morley M., Burdick J.T., Fiori J.L., Ewens W.J., Spielman R.S., and Cheung V.G. Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am. J. Hum. Genet. 71 (2002) 791-800
16. Pressman S., and Rotter J.I. Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique. Am. J. Hum. Genet. 49 (1991) 467
17. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) P3
18. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 10 (2003) R70
19. Gunderson K.L., Kruglyak S., Graige M.S., Garcia F., Kermani B.G., Zhao C., Che D., Dickinson T., Wickham E., Bierle J., Doucet D., Milewski M., Yang R., Siegmund C., Haas J., Zhou L., Oliphant A., Fan J.B., Barnard S., and Chee M.S. Decoding randomly ordered DNA arrays. Genome Res. 14 (2004) 870-877
20. Kuhn K., Baker S.C., Chudin E., Lieu M.H., Oeser S., Bennett H., Rigault P., Barker D., McDaniel T.K., and Chee M.S. A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res. 14 (2004) 2347-2356
21. Ruggero D., Grisendi S., Piazza F., Rego E., Mari F., Rao P.H., Cordon-Cardo C., and Pandolfi P.P. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299 (2003) 259-262
22. Yoon A., Peng G., Brandenburger Y., Zollo O., Xu W., Rego E., and Ruggero D. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312 (2006) 902-906
23. Patton J.R. Pseudouridine formation in small nuclear RNAs. Biochimie 76 (1994) 1129-1132
24. Koonin E.V. Pseudouridine synthases: four families of enzymes containing a putative uridine-binding motif also conserved in dUTPases and dCTP deaminases. Nucleic Acids Res. 24 (1996) 2411-2415
25. Massenet S., Mougin A., and Branlant C. Posttranscriptional modifications in the U small nuclear RNAs. In: Grosjean H., and Benne R. (Eds). The Modification and Editing of RNA (1998), ASM Press, Washington, DC 201-228
26. Charette M., and Gray M.W. Pseudouridine in RNA: what, where, how, and why. IUBMB Life 49 (2000) 341-351
27. Ofengand J. Ribosomal RNA pseudouridines and pseudouridine synthases. FEBS Lett. 514 (2002) 17-25
28. Motorin Y., Keith G., Simon C., Foiret D., Simos G., Hurt E., and Grosjean H. The yeast tRNA:pseudouridine synthase Pus1p displays a multisite substrate specificity. RNA 4 (1998) 856-869
29. Massenet S., Motorin Y., Lafontaine D.L., Hurt E.C., Grosjean H., and Branlant C. Pseudouridine mapping in the Saccharomyces cerevisiae spliceosomal U small nuclear RNAs (snRNAs) reveals that pseudouridine synthase Pus1p exhibits a dual substrate specificity for U2 snRNA and tRNA. Mol. Cell. Biol. 19 (1999) 2142-2154
30. Behm-Ansmant I., Urban A., Ma X., Yu Y.-T., Motorin Y., and Branlant C. The Saccharomyces cerevisiae U2 snRNA:pseudouridine-synthase Pus7p is a novel multisite-multisubstrate RNA:{Psi}-synthase also acting on tRNAs. RNA 9 (2003) 1371-1382
31. Chen J., and Patton J.R. Mouse pseudouridine synthase 1: gene structure and alternative splicing of pre-mRNA. Biochem J. 352 (2000) 465-473
32. Makita T., Hernandez-Hoyos G., Chen T.H., Wu H., Rothenberg E.V., and Sucov H.M. A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4. Genes Dev. 15 (2001) 889-901
33. Weiss G., Houston T., Kastner S., Johrer K., Grunewald K., and Brock J.H. Regulation of cellular iron metabolism by erythropoiet. Activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood 89 (1997) 680-687
34. Busfield S.J., Tilbrook P.A., Callus B.A., Spadaccini A., Kuhn L., and Klinken S.P. Complex regulation of transferrin receptors during erythropoietin-induced differentiation of J2E erythroid cells-elevated transcription and mRNA stabilisation produce only a modest rise in protein content. Eur. J. Biochem. 249 (1997) 77-84
35. Zoller H., Decristoforo C., and Weiss G. Erythroid 5-aminolevulinate synthase, ferrochelatase and DMT1 expression in erythroid progenitors: differential pathways for erythropoietin and iron-dependent regulation. Br. J. Haematol. 118 (2002) 619-626
36. Klausner R.D., and Rouault T.A. A double life: cytosolic aconitase as a regulatory RNA binding protein. Mol. Biol. Cell 4 (1993) 1-5
37. Hentze M.W., and Kuhn L.C. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93 (1996) 8175-8182
38. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89 (1997) 1-25
39. Hanson E.S., and Leibold E.A. In: Templeton D.M. (Ed). Molecular Cellular Iron Transport (2002), M. Dekker, New York 207-235
40. Sadlon T.J., Dell'Oso T., Surinya K.H., and May B.K. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis. Int. J. Biochem. Cell Biol. 31 (1999) 1153-1167
41. Casey J.L., Koeller D.M., Ramin V.C., Klausner R.D., and Harford J.B. Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J. 8 (1989) 3693-3699
42. Theil E.C. Regulation of ferritin and transferrin receptor mRNAs. J. Biol. Chem. 265 (1990) 4771-4774
43. Hube F., Guo J., Chooniedass-Kothari S., Cooper C., Hamedani M.K., Dibrov A.A., Blanchard A.A., Wang X., Deng G., Myal Y., and Leygue E. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol. 25 (2006) 418-428